The Top 100 Pharmaceutical Companies

The Top 100 Pharmaceutical Companies, determined by total sales in 2011 - see below for 2010 and  2009: They are listed in descending order with the sales in 2011 in $ million; Pfizer ...

ALK-Abello gains on allergy data

ALK-Abello A/S (CSE:ALK-B) gained DKK20.50 to DKK383.50 on Tuesday after its grass Allergy Immunotherapy Tablet (AIT) met the primary endpoint in a Phase III trial to treat grass pollen-induced allerg...

FDA to review grass allergy tablet

ALK-Abello A/S (CSE:ALK-B) and partner Merck & Co. Inc. (NYSE:MRK) said FDA accepted for review a BLA from Merck for grass Allergy Immunotherapy Tablet (AIT). Merck said it expects a decision on the a...

ALK Abello partner Torii progresses Japanese development of Mitizax

Denmark-based allergy specialist ALK Abello (ALKB: DC) revealed yesterday that its strategic partner, Japan-based Torii Pharma (TSE:4551), is advancing the clinical development program for Mitizax, th...

ALK-Abello, Merck sales and marketing update

ALK-Abello, Japan Tobacco, Torii deal

FDA to review ragweed allergy tablet

Merck & Co. Inc. (NYSE:MRK) said FDA accepted for review a BLA for Ragweed Allergy Immunotherapy Tablet (AIT) in adults with ragweed-induced allergic rhinitis. The pharma submitted the BLA in March an...

Merck & Co to initiate Ph III trial with HDM AIT (Mitizax) in North America

US pharma giant Merck & Co (NYSE: MRK) is planning to advance the clinical development program for the house dust mite allergy immunotherapy tablet (HDM AIT, also known as Mitizax in Europe) by initia...

P #1: “The Payer”

Précis:  In the first of Kevin's four-part "P" series, he talks to Peder Anderssen of ALK Abello about payers, the shift in decision-m...

Indoor mite allergen levels, specific IgE prevalence and IgE cross-inhibition pattern among asthmatic children in Haikou, southern China.

Haikou locates in tropical island with unique mite propagation. The aim of this stuy is to determine mite allergens levels in Haikou, and to investigate the prevalence of mite specific IgE-sensitizati...